Loading…
Loading grant details…
| Funder | Medical Research Council |
|---|---|
| Recipient Organization | University of Oxford |
| Country | United Kingdom |
| Start Date | Sep 30, 2024 |
| End Date | Sep 29, 2028 |
| Duration | 1,460 days |
| Number of Grantees | 1 |
| Roles | Student |
| Data Source | UKRI Gateway to Research |
| Grant ID | 2922783 |
This project focuses on transposable elements (TEs), which make up nearly 50% of the human genome and are linked to various diseases.
LINE1, a significant class of TEs, accounts for 17% of the genome and remains active in moving within it, making it crucial to understand its role in diseases such as haemophilia, Duchenne muscular dystrophy, and Dent disease.
The primary goal is to develop and optimize target enrichment methods for nanopore-based direct RNA sequencing to accurately analyse LINE1 RNA, addressing challenges like low read counts and high error rates without the need for reverse transcription or PCR, thereby reducing biases and improving accuracy.
With a chemistry background, the student will acquire skills in genomic research while enhancing communication and engagement abilities by considering the ethical implications of the work and participating in public outreach.
By uncovering the full LINE1 sequence, the project could lead to small molecule inhibitors that prevent LINE1 insertions, advancing treatments for genetic diseases and personalized medicine.
University of Oxford
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant